Local recurrence of malignant tumor of esophagus (disorder)
Clinical trial: Cytofloc
Year Started: 2018
Evaluation of a Non-Endoscopic Immunocytological Device (Cytosponge™) for post chemo-radiotherapy surveillance in patients with oesophageal cancer – a feasibility study
- Access:
- Closed to access
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
-
No restrictions
Associated Data Type |
Procurement Timeframe |
Followup records |
0 - 3 months |
Pathology records |
0 - 3 months |
Physiological/biochemical measurements |
0 - 3 months |
Survey data |
0 - 3 months |
Treatment records |
0 - 3 months |
Female
Young adult (18 - 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Biopsy (procedure) |
RT |
N/A |
Not applicable |
0 - 10% |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Male
Adult (> 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Biopsy (procedure) |
RT |
N/A |
Not applicable |
0 - 10% |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Female
Adult (> 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Biopsy (procedure) |
RT |
N/A |
Not applicable |
0 - 10% |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Male
Young adult (18 - 40 years)
1 - 10 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Biopsy (procedure) |
RT |
N/A |
Not applicable |
0 - 10% |
Plasma |
|
-60°C to -85°C |
N/A |
Not applicable |
0 - 10% |
Barrett's esophagus (disorder)
Clinical Trial: AspECT
Year Started: 2005
AspECT: A Phase III, Randomised Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia. Trial has 10-year follow up period with samples collected throughout. Patient age groups given in the Sample Sets are the age of the patients at trial randomisation
- Access:
- Open to applicants
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
-
Commercial restriction, DNA restriction
Associated Data Type |
Procurement Timeframe |
Followup records |
0 - 3 months |
Pathology records |
3 - 6 months |
Physiological/biochemical measurements |
0 - 3 months |
Treatment records |
0 - 3 months |
Male
Adult (> 40 years)
1001 - 3000 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
51 - 75% |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
51 - 75% |
Male
Young adult (18 - 40 years)
101 - 500 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
51 - 75% |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
51 - 75% |
Female
Adult (> 40 years)
101 - 500 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
51 - 75% |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
51 - 75% |
Female
Young adult (18 - 40 years)
11 - 100 donors
Material Type |
Extraction Procedure |
Storage Temperature |
Preservation Type |
Macroscopic Assessment |
% of Sample Set |
Tissue specimen |
Surgical procedure (procedure) |
RT |
Paraffin |
Affected |
51 - 75% |
Whole blood |
|
-60°C to -85°C |
N/A |
Not applicable |
51 - 75% |